AI assistant
Sending…
Lineage Cell Therapeutics Inc. — Proxy Solicitation & Information Statement 2016
May 4, 2016
6895_rns_2016-05-04_378c5cf5-5d84-404d-bed1-225e90333e84.htm
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
_________ false
C002������� ����2Public.BIOTIME, INC10834Corporation no: 876343Stock Exchange/Market: -13041380HARBOR BAY PARKWAY 1301 , ALAMEDA 94502 , CALIFORNIA , U.S.ATel: 5105213390 , Fax: 5105213389E.mail address: [email protected] via MAGNA: 04/05/2016 Time of broadcast: 09:26 09:21:05
| Company site: | biotimeinc.com |
Reference: 2016-02-058687
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on INFORMATION REQUIRED IN PROXY STATEMENT. ����� ����� ���� ����� ������ ����� ������. |
| Report_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: |
| Date of revision of form structure: 03/04/2016 |
| - - - |
| Name of the Signatory: : Gerzi Ilan , Position of Signatory in the reporting corporation: Attorney/Legal Counsel , Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ . |
| Harbor Bay Parkway 1301 Alameda 94502 Telephone: 510-5213390 , Facsimile: 510-5213389 , E-mail: [email protected] 1 |
More from Lineage Cell Therapeutics Inc.
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Report Publication Announcement
2026
May 13
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4